Recent Research | Page 77 | Aplastic Anemia and MDS International Foundation

Recent Research

Compiled for your convenience are the latest articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology. Articles are obtained from the National Library of Medicine’s MEDLINE database and date back to 2010.

Article Title Original Publication Date Journalsort descending Bone Marrow Disease
Anemia as the Main Manifestation of Myelodysplastic Syndromes Oct 2015 Semin Hematol myelodysplastic syndromes (MDS)
Clinical results with the DNA hypomethylating agent 5-aza-2'-deoxycytidine (decitabine) in patients with myelodysplastic syndromes: an update Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Lenalidomide for del(5q) and Non-del(5q) Myelodysplastic Syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Overview of myelodysplastic syndromes Oct 2012 Semin Hematol myelodysplastic syndromes (MDS)
Alternative donor transplants for severe aplastic anemia: current experience Jan 2016 Semin Hematol aplastic anemia
Aplastic anemia: what have we learned from animal models and from the clinic. Jun 2013 Semin Hematol aplastic anemia
Impaired proliferative potential of bone marrow mesenchymal stem cells in patients with myelodysplastic syndromes is associated with abnormal WNT signaling pathway Mar 2014 Stem Cells Dev myelodysplastic syndromes (MDS)
Safety and efficacy of azacitidine in elderly patients with intermediate to high-risk myelodysplastic syndromes Jan 2017 Ther Adv Hematol myelodysplastic syndromes (MDS)
Management of thrombosis in paroxysmal nocturnal hemoglobinuria: a clinician's guide Mar 2017 Ther Adv Hematol paroxysmal nocturnal hemoglobinuria (PNH)